CAP1-6D
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAP1-6D, covering 2014-03-14 to 2014-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma [Phase 1, Phase 2]